Waters Corporation has launched the BD FACSDiscover A7 Cell Analyzer, a new flow cytometry device that offers high spectral resolution and sensitivity with advanced standardization features. It enables researchers to analyze over 50 cell parameters consistently, improving reproducibility and confidence in data across labs. The device integrates BD SpectralFX and FACSTruQ technologies for automated calibration and quality control, speeding up research in immunology and drug development. Now available globally, it aims to make advanced cell analysis more accessible to academia, pharma, and contract research organizations.
Waters Corporation's launch of the BD FACSDiscover A7 Cell Analyzer comes as the health sector on Pluang shows mixed activity. For readers following health stocks, here is Pluang's market snapshot as of Sep 14, 2026 18:52 WIB: out of 91 priced US health-sector stocks, 50 rose and 28 fell. Notable movers include Medtronic PLC (MDT) up 2.55% at USD 93.28, AbCellera Biologics Inc (ABCL) down 2.30% at USD 10.64, and Twist Bioscience Corp (TWST) down 1.93% at USD 124.77.
BioNTech's experimental cancer treatment BNT113, combined with pembrolizumab, failed to show a significant improvement in progression-free survival in its Phase 2/3 AHEAD-MERIT trial. Despite missing this first primary endpoint, the trial will procee...
Wells Fargo reported third-quarter 2026 earnings per share (EPS) of $1.87, surpassing analyst estimates of $1.85, while revenue came in at $21.87 billion, below the expected $22.31 billion. The bank saw a 13% rise in EPS and a 6% increase in net inco...
Bank of America is set to report Q3 earnings with analysts expecting $1.10 per share and $30.54 billion in revenue, up from last year. CEO Brian Moynihan forecasts a 10% drop in investment banking fees and flat trading revenue. The bank's stock has f...
Reach Security secured over $50 million in Series B funding led by Top Tier Capital Partners to enhance its AI-driven cybersecurity platform. The company’s technology autonomously identifies and closes security gaps faster than AI-powered attackers c...
Rexel Développement SAS announced the total number of its shares and voting rights as of October 1, 2026. The company holds 311,385,744 shares, with a theoretical voting right count matching this number. However, the exercisable voting rights, exclud...
